These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21704587)

  • 1. RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.
    McClendon AK; Dean JL; Ertel A; Fu Z; Rivadeneira DB; Reed CA; Bourgo RJ; Witkiewicz A; Addya S; Mayhew CN; Grimes HL; Fortina P; Knudsen ES
    Gastroenterology; 2011 Oct; 141(4):1439-50. PubMed ID: 21704587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
    Mayhew CN; Carter SL; Fox SR; Sexton CR; Reed CA; Srinivasan SV; Liu X; Wikenheiser-Brokamp K; Boivin GP; Lee JS; Aronow BJ; Thorgeirsson SS; Knudsen ES
    Gastroenterology; 2007 Sep; 133(3):976-84. PubMed ID: 17854601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model.
    McClendon AK; Dean JL; Ertel A; Knudsen ES
    PLoS One; 2010 Jan; 5(1):e8558. PubMed ID: 20049321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
    Rivadeneira DB; Mayhew CN; Thangavel C; Sotillo E; Reed CA; Graña X; Knudsen ES
    Gastroenterology; 2010 May; 138(5):1920-30. PubMed ID: 20100483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb.
    Matondo RB; Toussaint MJ; Govaert KM; van Vuuren LD; Nantasanti S; Nijkamp MW; Pandit SK; Tooten PC; Koster MH; Holleman K; Schot A; Gu G; Spee B; Roskams T; Rinkes IB; Schotanus B; Kranenburg O; de Bruin A
    Oncotarget; 2016 Aug; 7(34):54662-54675. PubMed ID: 27323406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RB tumor suppressive function in response to xenobiotic hepatocarcinogens.
    Reed C; Hutcheson J; Mayhew CN; Witkiewicz AK; Knudsen ES
    Am J Pathol; 2014 Jun; 184(6):1853-9. PubMed ID: 24726645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1.
    Reed CA; Mayhew CN; McClendon AK; Yang X; Witkiewicz A; Knudsen ES
    Oncogene; 2009 Dec; 28(50):4434-43. PubMed ID: 19838213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control.
    Reed CA; Mayhew CN; McClendon AK; Knudsen ES
    J Biol Chem; 2010 Jan; 285(2):1089-96. PubMed ID: 19887370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt and mTORC1 have different roles during liver tumorigenesis in mice.
    Kenerson HL; Yeh MM; Kazami M; Jiang X; Riehle KJ; McIntyre RL; Park JO; Kwon S; Campbell JS; Yeung RS
    Gastroenterology; 2013 May; 144(5):1055-65. PubMed ID: 23376645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression.
    Nantasanti S; Toussaint MJ; Youssef SA; Tooten PC; de Bruin A
    PLoS One; 2016; 11(3):e0150064. PubMed ID: 26967735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.
    Markey MP; Bergseid J; Bosco EE; Stengel K; Xu H; Mayhew CN; Schwemberger SJ; Braden WA; Jiang Y; Babcock GF; Jegga AG; Aronow BJ; Reed MF; Wang JY; Knudsen ES
    Oncogene; 2007 Sep; 26(43):6307-18. PubMed ID: 17452985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation between Rb and Arf in suppressing mouse retinoblastoma.
    Conkrite K; Sundby M; Mu D; Mukai S; MacPherson D
    J Clin Invest; 2012 May; 122(5):1726-33. PubMed ID: 22484813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins.
    Vilas JM; Ferreirós A; Carneiro C; Morey L; Da Silva-Álvarez S; Fernandes T; Abad M; Di Croce L; García-Caballero T; Serrano M; Rivas C; Vidal A; Collado M
    Oncotarget; 2015 Feb; 6(5):2992-3002. PubMed ID: 25576924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.
    Cheng L; Zhou Z; Flesken-Nikitin A; Toshkov IA; Wang W; Camps J; Ried T; Nikitin AY
    Oncogene; 2010 Oct; 29(42):5700-11. PubMed ID: 20676140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer.
    Knudsen ES; McClendon AK; Franco J; Ertel A; Fortina P; Witkiewicz AK
    Cell Cycle; 2015; 14(1):109-22. PubMed ID: 25602521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis.
    Shinohara H; Zhou J; Yoshikawa K; Yazumi S; Ko K; Yamaoka Y; Mizukami T; Yoshida T; Akinaga S; Tamaoki T; Motoda H; Benedict WF; Takahashi R
    Br J Cancer; 2000 Oct; 83(8):1039-46. PubMed ID: 10993652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
    Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.